Akzo Nobel N.V.
AKZA.AS · AMS
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | €2,547,000 | €2,626,000 | €2,613,000 | €2,619,000 |
| % Growth | -3% | 0.5% | -0.2% | – |
| Cost of Goods Sold | €1,520,000 | €1,588,000 | €1,565,000 | €1,593,000 |
| Gross Profit | €1,027,000 | €1,038,000 | €1,048,000 | €1,026,000 |
| % Margin | 40.3% | 39.5% | 40.1% | 39.2% |
| R&D Expenses | €0 | €0 | €0 | €296,000 |
| G&A Expenses | €0 | €826,000 | €855,000 | €898,000 |
| SG&A Expenses | €743,000 | €826,000 | €855,000 | €898,000 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €0 | -€2,000 | €1,000 | -€295,000 |
| Operating Expenses | €743,000 | €824,000 | €856,000 | €899,000 |
| Operating Income | €284,000 | €214,000 | €192,000 | €127,000 |
| % Margin | 11.2% | 8.1% | 7.3% | 4.8% |
| Other Income/Exp. Net | -€380,000 | -€35,000 | -€23,000 | -€32,000 |
| Pre-Tax Income | -€96,000 | €179,000 | €169,000 | €95,000 |
| Tax Expense | €94,000 | €44,000 | €48,000 | €59,000 |
| Net Income | -€194,000 | €124,000 | €107,000 | €21,000 |
| % Margin | -7.6% | 4.7% | 4.1% | 0.8% |
| EPS | -1.13 | 0.73 | 0.63 | 0.12 |
| % Growth | -254.8% | 15.9% | 425% | – |
| EPS Diluted | -1.13 | 0.72 | 0.62 | 0.12 |
| Weighted Avg Shares Out | 171,000 | 171,000 | 170,800 | 170,800 |
| Weighted Avg Shares Out Dil | 171,000 | 172,222 | 172,581 | 170,800 |
| Supplemental Information | – | – | – | – |
| Interest Income | €12,000 | €18,000 | €0 | €0 |
| Interest Expense | €45,000 | €68,000 | €30,000 | €36,000 |
| Depreciation & Amortization | €94,000 | €92,000 | €94,000 | €94,000 |
| EBITDA | €34,000 | €339,000 | €293,000 | €225,000 |
| % Margin | 1.3% | 12.9% | 11.2% | 8.6% |